Weight loss program using mobile health technology for obese young patients after stem cell transplant
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
This study is testing a mobile health program to help obese young people aged 13-30 who have had a stem cell transplant lose weight and improve their eating habits over four months.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 13 Years to 30 Years |
| Sex | All |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT04997473 on ClinicalTrials.gov |
What this trial studies
This pilot study focuses on obese adolescents and young adults aged 13-30 who have undergone hematopoietic stem cell transplantation (HSCT). Participants will engage in a mobile health (mHealth) weight loss intervention that includes coaching and support over a four-month period. The study will assess changes in body mass index (BMI), metabolic metrics, and eating behaviors through regular check-ins and the use of a dedicated app. A total of 20 patients will be recruited from the hematology/oncology clinic at UCLA Mattel Children's Hospital.
Who should consider this trial
Good fit: Ideal candidates are obese adolescents and young adults aged 13-30 who are at least 100 days post-HSCT.
Not a fit: Patients who are under 13 or over 30 years old, or who do not meet the obesity criteria, will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could help improve weight management and overall health outcomes for young patients post-HSCT.
How similar studies have performed: Previous studies have validated the feasibility of mobile health interventions for weight loss, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study. * Both male and female patients will be eligible. * Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender. * Patients must also be able to read English since the app intervention is only available in English form. Exclusion Criteria: * Patients who are ≤ 13 or ≥ 30 years old are not eligible for the study. * Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \>100 days post-transplant at their next consultation that falls within the enrollment window. * Patients whose BMI does not fall under the obese category will be excluded. * No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation.
Where this trial is running
Los Angeles, California
- UCLA Mattel Children's Hospital — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Theodore B Moore, MD — UCLA Health
- Study coordinator: Belen Ramirez
- Email: belenramirez@mednet.ucla.edu
- Phone: 3102670425
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.